The selective orexin receptor 1 antagonist ACT-335827 in a rat model of diet-induced obesity associated with metabolic syndrome.

Steiner, Michel A; Sciarretta, Carla; Pasquali, Anne; Jenck, Francois

Steiner, Michel A; Sciarretta, Carla; Pasquali, Anne; Jenck, Francois.

Afiliación

Steiner MA; CNS Pharmacology Neurobiology, Actelion Pharmaceuticals Ltd. Allschwil, Switzerland.
Sciarretta C; Immunology, Actelion Pharmaceuticals Ltd. Allschwil, Switzerland.
Pasquali A; Cardiology, Actelion Pharmaceuticals Ltd. Allschwil, Switzerland.
Jenck F; CNS Pharmacology Neurobiology, Actelion Pharmaceuticals Ltd. Allschwil, Switzerland.

Front Pharmacol ; 4: 165, 2013.

Article en En | MEDLINE | ID: mdl-24416020

Palabras clave

ACT-335827; diet-induced obesity; food intake; food preference; lipid metabolism; metabolic syndrome; orexin; orexin receptor antagonist

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2013 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google